Form 4 for AYTU AYTU BIOPHARMA, INC
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-05 · accession 0000912282-25-000223 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-02-05 | AYTU | Selhorn Ryan J | CFO | M - OptEx | — | +105 | 16.0K | +0.7% | — |
| D | 2025-03-03 | 2025-02-05 | AYTU | Selhorn Ryan J | CFO | M - OptEx | $0.00 | -105 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-02-05 | M | A | 105 | — | 16,000 | D | — | — | (F1) Restricted stock units (RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted February 5, 2022, vesting quarterly beginning February 5, 2023, and ending February 5, 2025. |
| 2 | Derivative | Restricted Stock Units | 2025-02-05 | M | D | 105 | $0.00 | 0 | D | — · — to — | 105 Common Shares | (F1) Restricted stock units (RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted February 5, 2022, vesting quarterly beginning February 5, 2023, and ending February 5, 2025. |